000 00356nam a22001097a 4500
008 221001b |||||||| |||| 00| 0 eng d
020 _aNA
100 _aAGRAWAL, Ayushi
245 _aAn approach on current regulatory considerations of adverse event reporting & pharmacovigilance for biologics in India and US
300 _aviii, 148
942 _2ddc
_cACPCD
999 _c398136
_d398136